TXLNGY | taxilin gamma pseudogene, Y-linked | Yq11.222 | 1.556 | 0.915 | 0
|
USP9Y | ubiquitin specific peptidase 9, Y-linked | Yq11.2 | 1.544 | 0.928 | 0
|
KDM5D | lysine (K)-specific demethylase 5D | Yq11 | 1.418 | 0.918 | 0
|
TTTY15 | testis-specific transcript, Y-linked 15 (non-protein coding) | Yq11.1 | 1.367 | 0.891 | 0
|
EIF1AY | eukaryotic translation initiation factor 1A, Y-linked | Yq11.223 | 1.326 | 0.86 | 0
|
DDX3Y | DEAD (Asp-Glu-Ala-Asp) box helicase 3, Y-linked | Yq11 | 1.31 | 0.929 | 0
|
TMSB4Y | thymosin beta 4, Y-linked | Yq11.221 | 1.249 | 0.873 | 0
|
ZFY | zinc finger protein, Y-linked | Yp11.3 | 1.084 | 0.862 | 0
|
NLGN4Y | neuroligin 4, Y-linked | Yq11.221 | 1.084 | 0.895 | 0
|
RPS4Y1 | ribosomal protein S4, Y-linked 1 | Yp11.3 | 1 | 0.824 | 0
|
PRKY | protein kinase, Y-linked, pseudogene | Yp11.2 | 0.996 | 0.854 | 0
|
TTTY14 | testis-specific transcript, Y-linked 14 (non-protein coding) | Yq11.222 | 0.971 | 0.751 | 0
|
FAM224B | family with sequence similarity 224, member B (non-protein coding) | Yq11.221 | 0.87 | 0.698 | 0
|
BCORP1 | BCL6 corepressor pseudogene 1 | Yq11.222 | 0.84 | 0.678 | 0
|
DAZ1 | deleted in azoospermia 1 | Yq11.223 | 0.668 | 0.506 | 0
|
TSIX | TSIX transcript, XIST antisense RNA | Xq13.2 | 0.547 | -0.593 | 0
|
XIST | X inactive specific transcript (non-protein coding) | Xq13.2 | 0.54 | -0.629 | 0
|
HSFY2 | heat shock transcription factor, Y-linked 2 | Yq11.221 | 0.486 | 0.646 | 0
|
TBL1Y | transducin (beta)-like 1, Y-linked | Yp11.2 | 0.459 | 0.629 | 0
|
NBPF6 | neuroblastoma breakpoint family, member 6 | 1p13.3 | 0.385 | 0.061 | 0.205
|
HBE1 | hemoglobin, epsilon 1 | 11p15.5 | 0.356 | -0.078 | 0.106
|
COX7B2 | cytochrome c oxidase subunit VIIb2 | 4p12 | 0.342 | -0.061 | 0.212
|
LIN28B | lin-28 homolog B (C. elegans) | 6q21 | 0.338 | -0.004 | 0.931
|
OOEP | oocyte expressed protein | 6q13 | 0.327 | 0.061 | 0.21
|
DSCR8 | Down syndrome critical region 8 | 21q22.2 | 0.326 | -0.045 | 0.356
|
ESX1 | ESX homeobox 1 | Xq22.2 | 0.326 | -0.014 | 0.773
|
NXPH2 | neurexophilin 2 | 2q22.1 | 0.32 | 0.054 | 0.266
|
DSCR4 | Down syndrome critical region 4 | 21q22.2 | 0.304 | -0.051 | 0.295
|
SPDYC | speedy/RINGO cell cycle regulator family member C | 11q13.1 | 0.292 | 0.068 | 0.163
|
LINC00470 | long intergenic non-protein coding RNA 470 | 18p11.32 | 0.288 | -0.061 | 0.205
|
MAGEA8 | melanoma antigen family A8 | Xq28 | 0.281 | 0.079 | 0.103
|
TLX3 | T-cell leukemia homeobox 3 | 5q35.1 | 0.278 | 0.003 | 0.945
|
TMEM150B | transmembrane protein 150B | 19q13.42 | 0.276 | -0.144 | 0.00295
|
CD72 | CD72 molecule | 9p | 0.276 | -0.14 | 0.00372
|
CENPA | centromere protein A | 2p23.3 | 0.275 | -0.157 | 0.00115
|
LEFTY2 | left-right determination factor 2 | 1q42.1 | 0.271 | -0.129 | 0.00747
|
CFAP47 | cilia and flagella associated protein 47 | Xp21.1 | 0.261 | 0.064 | 0.185
|
AKAP17A | A kinase (PRKA) anchor protein 17A | Xp22.33 and Yp11.32 | 0.258 | 0.356 | 4.77e-14
|
PLCH2 | phospholipase C, eta 2 | 1p36.32 | 0.255 | 0.163 | 0.000751
|
EEA1 | early endosome antigen 1 | 12q22 | 0.253 | 0.154 | 0.00141
|
PUDP | pseudouridine 5'-phosphatase | Xp22.32 | 0.251 | -0.237 | 8.24e-07
|
LDLRAD4 | low density lipoprotein receptor class A domain containing 4 | 18p11.21 | 0.251 | 0.075 | 0.121
|
PLA2G4E | phospholipase A2, group IVE | 15q15.1 | 0.249 | -0.013 | 0.797
|
COBLL1 | cordon-bleu WH2 repeat protein-like 1 | 2q24.3 | 0.246 | 0.187 | 0.000109
|
PTPRQ | protein tyrosine phosphatase, receptor type, Q | 12q21.31 | 0.245 | 0.169 | 0.000478
|
USP27X-AS1 | USP27X antisense RNA 1 (head to head) | Xp11.23 | 0.241 | 0.1 | 0.0392
|
ATP2C2 | ATPase, Ca++ transporting, type 2C, member 2 | 16q24.1 | 0.241 | 0.133 | 0.00612
|
GEMIN6 | gem (nuclear organelle) associated protein 6 | 2p22.1 | 0.241 | -0.21 | 1.23e-05
|
CAPNS2 | calpain, small subunit 2 | 16q12.2 | 0.24 | 0.111 | 0.0221
|
ALDH1B1 | aldehyde dehydrogenase 1 family, member B1 | 9p13 | 0.24 | -0.116 | 0.0162
|
FAN1 | FANCD2/FANCI-associated nuclease 1 | 15q13.2-q13.3 | 0.24 | 0.056 | 0.251
|
RNF103 | ring finger protein 103 | 2p11.2 | 0.237 | 0.128 | 0.00811
|
NWD2 | NACHT and WD repeat domain containing 2 | 4p14 | 0.236 | 0.093 | 0.0543
|
PPM1G | protein phosphatase, Mg2+/Mn2+ dependent, 1G | 2p23.3 | 0.236 | -0.174 | 0.000314
|
TIMM8A | translocase of inner mitochondrial membrane 8 homolog A (yeast) | Xq22 | 0.233 | -0.163 | 0.00071
|
CYSLTR1 | cysteinyl leukotriene receptor 1 | Xq13-q21 | 0.233 | 0.03 | 0.541
|
BCL2L15 | BCL2-like 15 | 1p13.2 | 0.232 | 0.054 | 0.265
|
DUOX1 | dual oxidase 1 | 15q21 | 0.231 | 0.16 | 0.000941
|
ZDHHC3 | zinc finger, DHHC-type containing 3 | 3p21.31 | 0.23 | 0.235 | 9.73e-07
|
ZNF24 | zinc finger protein 24 | 18q12 | 0.229 | 0.189 | 8.62e-05
|
NCAPH | non-SMC condensin I complex, subunit H | 2q11.2 | 0.228 | -0.134 | 0.00547
|
ZNF658 | zinc finger protein 658 | 9p13.1 | 0.228 | 0.145 | 0.00263
|
TMEFF1 | transmembrane protein with EGF-like and two follistatin-like domains 1 | 9q31 | 0.227 | -0.146 | 0.00259
|
SEC61G | Sec61 translocon gamma subunit | 7p11.2 | 0.227 | -0.236 | 9.14e-07
|
SLC38A2 | solute carrier family 38, member 2 | 12q13.11 | 0.226 | 0.06 | 0.213
|
MTSS1L | metastasis suppressor 1-like | 16q22.1 | 0.225 | 0.238 | 7.26e-07
|
PFDN2 | prefoldin subunit 2 | 1q23.3 | 0.224 | -0.069 | 0.153
|
DPH3 | diphthamide biosynthesis 3 | 3p25.1 | 0.221 | -0.095 | 0.0508
|
BTBD11 | BTB (POZ) domain containing 11 | 12q24.11 | 0.221 | 0.05 | 0.307
|
DBF4B | DBF4 zinc finger B | 17q21.31 | 0.22 | -0.078 | 0.107
|
NBPF4 | neuroblastoma breakpoint family, member 4 | 1p13.3 | 0.22 | 0.064 | 0.187
|
ACTG1P4 | actin gamma 1 pseudogene 4 | 1p21 | 0.219 | 0.111 | 0.022
|
NEK2 | NIMA-related kinase 2 | 1q32.3 | 0.219 | -0.104 | 0.0314
|
EIF1AX | eukaryotic translation initiation factor 1A, X-linked | Xp22.13 | 0.216 | -0.289 | 1.49e-09
|
AKAP13 | A kinase (PRKA) anchor protein 13 | 15q24-q25 | 0.214 | 0.062 | 0.2
|
NIPAL3 | NIPA-like domain containing 3 | 1p36.12-p35.1 | 0.21 | 0.11 | 0.0225
|
RASSF5 | Ras association (RalGDS/AF-6) domain family member 5 | 1q31 | 0.209 | 0.124 | 0.0105
|
IFRD1 | interferon-related developmental regulator 1 | 7q31.1 | 0.207 | -0.162 | 0.000812
|
PRAME | preferentially expressed antigen in melanoma | 22q11.22 | 0.206 | -0.163 | 0.000755
|
NRSN2 | neurensin 2 | 20p13 | 0.205 | -0.146 | 0.00255
|
C14orf159 | chromosome 14 open reading frame 159 | 14q32.11 | 0.205 | 0.091 | 0.0589
|
LSM1 | LSM1 homolog, mRNA degradation associated | 8p11.2 | 0.203 | -0.143 | 0.00299
|
ADRB1 | adrenoceptor beta 1 | 10q25.3 | 0.202 | 0.168 | 0.000494
|
ENDOU | endonuclease, polyU-specific | 12q13.1 | 0.199 | -0.014 | 0.772
|
TOM1L2 | target of myb1 like 2 membrane trafficking protein | 17p11.2 | 0.199 | 0.201 | 2.9e-05
|
ILF2 | interleukin enhancer binding factor 2 | 1q21.3 | 0.198 | -0.055 | 0.255
|
MLX | MLX, MAX dimerization protein | 17q21.1 | 0.198 | 0.001 | 0.991
|
UBE2V1 | ubiquitin-conjugating enzyme E2 variant 1 | 20q13.2 | 0.197 | -0.014 | 0.769
|
ADCY1 | adenylate cyclase 1 (brain) | 7p12.3 | 0.197 | 0.116 | 0.0163
|
CIDEA | cell death-inducing DFFA-like effector a | 18p11.21 | 0.196 | 0.043 | 0.371
|
HRSP12 | heat-responsive protein 12 | 8q22 | 0.195 | -0.177 | 0.000234
|
ZDHHC7 | zinc finger, DHHC-type containing 7 | 16q23.1 | 0.191 | 0.002 | 0.974
|
DAPL1 | death associated protein-like 1 | 2q24 | 0.19 | -0.033 | 0.501
|
SLC25A6 | solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 6 | Xp22.32 and Yp11.3 | 0.189 | 0.235 | 9.4e-07
|
SLC40A1 | solute carrier family 40 (iron-regulated transporter), member 1 | 2q32 | 0.187 | 0.039 | 0.418
|
SYT5 | synaptotagmin V | 19q13.42 | 0.185 | -0.226 | 2.57e-06
|
TEKT2 | tektin 2 (testicular) | 1p34.3 | 0.183 | -0.006 | 0.898
|
ZNF815P | zinc finger protein 815, pseudogene | 7p22.1 | 0.181 | -0.164 | 0.000666
|
CFAP45 | cilia and flagella associated protein 45 | 1q23.2 | 0.173 | 0.07 | 0.151
|
PNPLA4 | patatin-like phospholipase domain containing 4 | Xp22.3 | 0.169 | -0.205 | 1.98e-05
|